AIM

CleanTech Lithium: Invitation to PDAC 2024 Booth 2610

Retrieved on: 
Wednesday, February 21, 2024

Jersey, United Kingdom--(Newsfile Corp. - February 21, 2024) - Visit CleanTech Lithium (AIM: CTL) (OTCQX: CTLHF) at Booth #2610 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Key Points: 
  • Jersey, United Kingdom--(Newsfile Corp. - February 21, 2024) - Visit CleanTech Lithium (AIM: CTL) (OTCQX: CTLHF) at Booth #2610 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Directorate change

Retrieved on: 
Monday, March 11, 2024

The Company has initiated a process to appoint a new Chief Financial Officer and will update the market in due course.

Key Points: 
  • The Company has initiated a process to appoint a new Chief Financial Officer and will update the market in due course.
  • After a period of transition, he will leave the Company in a robust financial position and we wish him the best in his future endeavours."
  • “I have thoroughly enjoyed my three years working with the fantastic team at Amaroq and wish them continued success.
  • I will be leaving the business and its finances in healthy shape following a managed handover period to a successor."

TRILLION ENERGY ANNOUNCES CFO AND DIRECTOR CHANGE

Retrieved on: 
Friday, March 8, 2024

Vancouver, B.C., March 08, 2024 (GLOBE NEWSWIRE) -- Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) has announced the appointment of David Thompson as Interim CFO and a search for a permanent Chief Financial Officer (CFO).

Key Points: 
  • Vancouver, B.C., March 08, 2024 (GLOBE NEWSWIRE) -- Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) has announced the appointment of David Thompson as Interim CFO and a search for a permanent Chief Financial Officer (CFO).
  • David Thompson, a director and former CFO of the Company has agreed to act and has been appointed as interim CFO until a new permanent CFO is appointed.
  • He has served as president and CEO of Sea Dragon Energy Inc. (London exchange: SDX), Financial Director of Forum Energy Plc (AIM) and SVP at Larmag Group of Companies.
  • Kubilay Yildirim has resigned as a director of Trillion Energy effective immediately.

AIM ImmunoTech Announces Launch of CEO Corner Platform

Retrieved on: 
Thursday, March 7, 2024

OCALA, Fla., March 07, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the launch of its CEO Corner featuring Thomas K Equels, M.S., J.D., Executive Vice Chairman, Chief Executive Officer & President of AIM ImmunoTech. The CEO Corner platform is intended to provide additional and in-depth perspective to press releases, corporate developments and development pipeline progress.

Key Points: 
  • CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress
    Access the AIM CEO Corner Here!
  • OCALA, Fla., March 07, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the launch of its CEO Corner featuring Thomas K Equels, M.S., J.D., Executive Vice Chairman, Chief Executive Officer & President of AIM ImmunoTech.
  • The CEO Corner platform is intended to provide additional and in-depth perspective to press releases, corporate developments and development pipeline progress.
  • “CEO Corner is a new way for us to connect directly with both current and potential stockholders.

Bango expands the Digital Vending Machine® with new streaming subscription services

Retrieved on: 
Tuesday, March 5, 2024

CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Bango (AIM:BGO) today announces three new partnerships, adding unique content to the Digital Vending Machine® from Sports.com, Cineshort, and BINGE Movies & TV.

Key Points: 
  • CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Bango (AIM:BGO) today announces three new partnerships, adding unique content to the Digital Vending Machine® from Sports.com, Cineshort, and BINGE Movies & TV.
  • This allows telcos, banks and other resellers to diversify the selection of subscription services available in their Super Bundling content hubs, accelerating their time to market.
  • Resellers that have standardized on the Digital Vending Machine® to offer subscription bundles can now seamlessly incorporate these services, enriching their content catalogue and providing consumers with an expanded range of streaming choices.
  • The newly added subscription services are immediately available, ensuring a quick and effortless process for resellers to introduce fresh, engaging content and enhance customer retention.

Sports.Com Announces Strategic Partnership With Bango to expand Its Global Footprint

Retrieved on: 
Tuesday, March 5, 2024

LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Sports.com, an innovator in sports entertainment, is delighted to announce a new strategic partnership with Bango PLC (AIM: BGO), (“Bango”), the global platform for subscriptions bundling.

Key Points: 
  • LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Sports.com, an innovator in sports entertainment, is delighted to announce a new strategic partnership with Bango PLC (AIM: BGO), (“Bango”), the global platform for subscriptions bundling.
  • The partnership will substantially extend the reach of Sports.com's unique sports content to new and untapped markets worldwide, leveraging Bango’s extensive international distribution network.
  • Trusted by leading technology companies, including Amazon, Google, and Microsoft, Bango facilitates direct access to millions of potential customers through its expansive network of partners.
  • Our partnership with Bango is a pivotal stage in our journey to revolutionise sports entertainment worldwide.

Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024

Retrieved on: 
Tuesday, March 5, 2024

Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024

Key Points: 
  • Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
    Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces updated clinical data from the First-in-Human Phase 1 trial of the peptide drug conjugate, AVA6000 will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting, taking place in San Diego, California from 5-10 April 2024.
  • The results will be presented in the Phase 1 Clinical Trials 2 Poster Session on April 9, 2024 as detailed below.
  • Title: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors
    First Author: Udai Banerji, MD, PhD, The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust
    For further information from Avacta Group plc, please contact:

Lenders One Brings Together Its Members and Providers to Help Members Increase Profitability During Challenging Markets

Retrieved on: 
Monday, March 4, 2024

The addition of these members amid the challenging mortgage origination environment is a testament to the Lenders One team and offerings.

Key Points: 
  • The addition of these members amid the challenging mortgage origination environment is a testament to the Lenders One team and offerings.
  • Today, Lenders One offers its members a variety of direct, capital markets and national programs solutions, to help its members better compete.
  • More recently, Lenders One launched and refined some of its direct solutions to enhance the value proposition for its members:
    L1 Credit and Resellers.
  • In addition to its direct solutions, Lenders One has a suite of Capital Market and National Program solutions to help the members better compete.

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

Retrieved on: 
Thursday, February 29, 2024

OCALA, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent accomplishments and provided a business outlook. AIM’s dsRNA product candidate, Ampligen® (rintatolimod), is being evaluated as a combinational therapy for the treatment of a variety of solid tumor types in multiple clinical trials – both underway and planned – at major cancer research centers around the country.

Key Points: 
  • OCALA, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent accomplishments and provided a business outlook.
  • AIM’s dsRNA product candidate, Ampligen® (rintatolimod), is being evaluated as a combinational therapy for the treatment of a variety of solid tumor types in multiple clinical trials – both underway and planned – at major cancer research centers around the country.
  • In addition to its ongoing clinical and business development activities, the Company will continue to engage with the industry and investment communities by actively participating in meetings, virtual events and key conferences over the course of the year.
  • To stay up to date with the Company’s activities visit aimimmuno.com and connect with the Company on X , LinkedIn , and Facebook .

Falcon Oil & Gas Ltd. - Stellar IP30 Day Flow Rates Advances the Beetaloo to Pilot Development

Retrieved on: 
Monday, February 26, 2024

The IP30 flow test extrapolates to ~19.5 MMcf/d for proposed future 10,000-foot (3,000 metres) development wells, in line with some of the highest flow rates achieved in the US Marcellus shale.

Key Points: 
  • The IP30 flow test extrapolates to ~19.5 MMcf/d for proposed future 10,000-foot (3,000 metres) development wells, in line with some of the highest flow rates achieved in the US Marcellus shale.
  • Flow testing of the SS-1H well will continue for the next 60 days to achieve average IP90 flow rates to better determine the well’s EUR.
  • The Beetaloo JV Partners of Falcon and Tamboran B2 Pty Limited will now progress development plans for the proposed 40 MMcf/d Pilot Project at the Shenandoah South location.
  • “The IP30 flow rate announced today of 3.2 MMcf/d, normalised to 6.4 MMcf/d over 1,000 metres, are truly stellar and mark a major turning point in the Beetaloo Basin.